UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Expression of Leptin and iNOS in Oral Melanomas in Dogs

Journal of veterinary internal medicine, 2013-09, Vol.27 (5), p.1278-1282

2013

Volltextzugriff (PDF)

Inducible Nitric Oxide Synthase and Nitrotyrosine in Human Metastatic Melanoma Tumors Correlate with Poor Survival

Clinical cancer research, 2000-12, Vol.6 (12), p.4768-4775

2000

Volltextzugriff (PDF)

Regulation of iNOS by the p44 42 mitogen-activated protein kinase pathway in human melanoma

Oncogene, 2006-06, Vol.25 (28), p.3956-3962

2006

Volltextzugriff (PDF)

Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer

Clinical cancer research, 1997-12, Vol.3 (12), p.2371-2376

1997

Volltextzugriff (PDF)

Coincident renal cell carcinoma and nonHodgkin's lymphoma : The M. D. Anderson experience and review of the literature

The Journal of urology, 1998-03, Vol.159 (3), p.714-717

1998

Volltextzugriff (PDF)

Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer

Cancer research (Chicago, Ill.), 2006-03, Vol.66 (6), p.3114-3119

2006

Volltextzugriff (PDF)

Intraabdominal desmoplastic small cell tumor: Report and discussion of five cases

Cancer, 1996-08, Vol.78 (4), p.845-851

1996

Volltextzugriff (PDF)

Loss of MDA-7 Expression With Progression of Melanoma

Journal of clinical oncology, 2002-02, Vol.20 (4), p.1069-1074

Ellerhorst, J. A.

2002

Volltextzugriff (PDF)

Down‐regulated melanoma differentiation associated gene (mda‐7) expression in human melanomas

International journal of cancer, 2001-10, Vol.94 (1), p.54-59

2001

Volltextzugriff (PDF)

MDA-7/IL-24 is a unique cytokine–tumor suppressor in the IL-10 Family

International immunopharmacology, 2004-05, Vol.4 (5), p.649-667

2004

Volltextzugriff (PDF)

2'-deoxy-5-azacytidine increases binding of cisplatin to DNA by a mechanism independent of DNA hypomethylation

British journal of cancer, 1993-02, Vol.67 (2), p.209-215

1993

Volltextzugriff (PDF)

Loss of MDA-7 expression with progression of melanoma

Journal of clinical oncology, 2002-02, Vol.20 (4), p.1069-1074

2002

Volltextzugriff (PDF)

Randomized Multicenter Phase II Trial of Subcutaneous Recombinant Human Interleukin-12 Versus Interferon-α2a for Patients with Advanced Renal Cell Carcinoma

Journal of interferon & cytokine research, 2001-04, Vol.21 (4), p.257-263

2001

Volltextzugriff (PDF)

A18. Constitutive intracellular production of NO in human melanoma regulates resistance to apoptosis

Nitric oxide, 2007, Vol.17, p.13-13

2007

Volltextzugriff (PDF)

Protamine Antibody Production in Diabetic Subjects Treated with NPH Insulin

The American journal of the medical sciences, 1990-05, Vol.299 (5), p.298-301

1990

Volltextzugriff (PDF)

Induction of differentiation and apoptosis in the prostate cancer cell line LNCaP by sodium butyrate and galectin-1

International journal of oncology, 1999-02, Vol.14 (2), p.225

1999

Volltextzugriff (PDF)

Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype

International journal of oncology, 1999-02, Vol.14 (2), p.217

1999

Volltextzugriff (PDF)

Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cells

Molecular cancer therapeutics, 2003-01, Vol.2 (1), p.9-17

2003

Volltextzugriff (PDF)

Expression of Thyrotropin-Releasing Hormone by Human Melanoma and Nevi

Clinical cancer research, 2004-08, Vol.10 (16), p.5531-5536

2004

Volltextzugriff (PDF)

Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer

Urolithiasis, 1999-10, Vol.27 (5), p.362-367

1999

Volltextzugriff (PDF)

Effects of galectin-3 expression on growth and tumorigenicity of the prostate cancer cell line LNCaP

The Prostate, 2002-01, Vol.50 (1), p.64-70

2002

Volltextzugriff (PDF)

HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC

Urologe. Ausgabe A, 2004-09, Vol.43 Suppl 3 (S3), p.S137-137

2004

Volltextzugriff (PDF)

A Phase II study of “decrescendo” interleukin‐2 plus interferon‐α‐2a in patients with progressive metastatic melanoma after chemotherapy

Cancer, 2000-04, Vol.88 (7), p.1703-1709

2000

Volltextzugriff (PDF)

Robin's place

Journal of Christian nursing, 1997, Vol.14 (3), p.8-9

Ellerhorst-Ryan, J M

1997

Volltextzugriff (PDF)

A phase II evaluation of bexarotene (Targretin) capsules in patients with metastatic melanoma

Oncology reports, 2000-07, Vol.7 (4), p.883

2000

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(38)

Publikationsform

Sprache

Englisch
(57)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(31)
Science & Technology
(26)
Life Sciences & Biomedicine
(25)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Oncology
(15)
Male
(11)
Nursing
(11)
Pharmacology. Drug Treatments
(8)
Antineoplastic Agents
(7)
Female
(7)
Gene Expression Regulation, Neoplastic
(7)
Melanoma - Pathology
(6)
Prostatic Neoplasms - Pathology
(6)
Immunohistochemistry
(5)
Middle Aged
(5)
Nephrology. Urinary Tract Diseases
(5)
Tumor Cells, Cultured
(5)
Tumors
(5)
Tumors Of The Urinary System
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Expression of Leptin and iNOS in Oral Melanomas in Dogs

Inducible Nitric Oxide Synthase and Nitrotyrosine in Human Metastatic Melanoma Tumors Correlate with Poor Survival

Regulation of iNOS by the p44 42 mitogen-activated protein kinase pathway in human melanoma

Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer

Coincident renal cell carcinoma and nonHodgkin's lymphoma : The M. D. Anderson experience and review of the literature

Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer

Intraabdominal desmoplastic small cell tumor: Report and discussion of five cases

Loss of MDA-7 Expression With Progression of Melanoma

Down‐regulated melanoma differentiation associated gene (mda‐7) expression in human melanomas

MDA-7/IL-24 is a unique cytokine–tumor suppressor in the IL-10 Family

2'-deoxy-5-azacytidine increases binding of cisplatin to DNA by a mechanism independent of DNA hypomethylation

Loss of MDA-7 expression with progression of melanoma

Randomized Multicenter Phase II Trial of Subcutaneous Recombinant Human Interleukin-12 Versus Interferon-α2a for Patients with Advanced Renal Cell Carcinoma

A18. Constitutive intracellular production of NO in human melanoma regulates resistance to apoptosis

Protamine Antibody Production in Diabetic Subjects Treated with NPH Insulin

Induction of differentiation and apoptosis in the prostate cancer cell line LNCaP by sodium butyrate and galectin-1

Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype

Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cells

Expression of Thyrotropin-Releasing Hormone by Human Melanoma and Nevi

Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer

Effects of galectin-3 expression on growth and tumorigenicity of the prostate cancer cell line LNCaP

HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC

A Phase II study of “decrescendo” interleukin‐2 plus interferon‐α‐2a in patients with progressive metastatic melanoma after chemotherapy

Robin's place

A phase II evaluation of bexarotene (Targretin) capsules in patients with metastatic melanoma

Aktive Filter

Suchergebnisse filtern